EUVIMEDEUVIMED entdecken
Crossref

Targeting Melanocortin Receptors Using S N Ar-Type Macrocyclization: A Doubly Orthogonal Route to Cyclic Peptide Conjugates

Wenxiao K Yue iD, Tianxia Zhang, Rekha Shandre Mugan, Nicholas Barlow iD, David K Chalmers iD, Colin W Pouton iD, Philip E Thompson iD

Journal of Medicinal Chemistry · 09.03.2023 · 66 (5) · 3273-3283

DOI: 10.1021/acs.jmedchem.2c01587 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 21.02.2023. Verfasst von Wenxiao K Yue und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia. Hauptthemen laut MEDLINE: Peptides, Cyclic, Peptides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: Monash Institute of Pharmaceutical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While a range of strategies exist to accomplish peptide macrocyclization, they are frequently limited by the need for orthogonal protection or provide little opportunity for structural diversification. We have evaluated an efficient macrocyclization method that employs nucleophilic aromatic substitution (SNAr) to create thioether macrocycles. This versatile macrocyclization, orthogonal to conventional peptide synthesis, can be performed in solution on unprotected peptidomimetics or on resin-bound peptides with side-chain protection in place. We show that the electron-withdrawing groups present in the products can be further utilized in subsequent orthogonal reactions to alter the peptide properties or to add prosthetic groups. The macrocyclization strategy was applied to the design of melanocortin ligands, generating a library of potent melanocortin agonists that exhibit distinct subtype selectivity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peptides, CyclicPeptidesCyclizationReceptors, MelanocortinGene Library

Substanzen

Peptides, CyclicPeptidesReceptors, Melanocortin

Autor:innen und Institutionen

  • Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia.
  • Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia.

ORCID-Profile: Wenxiao K Yue, Nicholas Barlow, David K Chalmers, Colin W Pouton, Philip E Thompson

Förderung

  • Monash Institute of Pharmaceutical Sciences

Zitieren

APA

Yue, W. K., Zhang, T., Shandre Mugan, R., Barlow, N., Chalmers, D. K., Pouton, C. W., & Thompson, P. E. (2023). Targeting Melanocortin Receptors Using S N Ar-Type Macrocyclization: A Doubly Orthogonal Route to Cyclic Peptide Conjugates. Journal of Medicinal Chemistry, 66(5), 3273-3283. https://doi.org/10.1021/acs.jmedchem.2c01587

Vancouver

Yue WK, Zhang T, Shandre Mugan R, Barlow N, Chalmers DK, Pouton CW, et al. Targeting Melanocortin Receptors Using S N Ar-Type Macrocyclization: A Doubly Orthogonal Route to Cyclic Peptide Conjugates. Journal of Medicinal Chemistry. 2023;66(5):3273-3283. doi:10.1021/acs.jmedchem.2c01587

BibTeX
@article{Yue2023,
  author = {Yue, Wenxiao K and Zhang, Tianxia and Shandre Mugan, Rekha and Barlow, Nicholas and Chalmers, David K and Pouton, Colin W and Thompson, Philip E},
  title = {Targeting Melanocortin Receptors Using S N Ar-Type Macrocyclization: A Doubly Orthogonal Route to Cyclic Peptide Conjugates},
  journal = {Journal of Medicinal Chemistry},
  year = {2023},
  volume = {66},
  number = {5},
  pages = {3273--3283},
  doi = {10.1021/acs.jmedchem.2c01587}
}
Kostenlos starten →